BSE : 78788
NSE : REMUS
Sector :Health care
ISIN Code : INE0O5T01011
NSE
2452.35
93.15 (3.95%)
BSE
(%)
Remus Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 09-Nov-2024 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2024 and Dividend/Other business.